Press Releases
Samsung Biologics to attend 2024 BIO International Convention
Samsung Biologics will be attending the 2024 BIO International Convention in San Diego between June 3-6 this year.
The company plans to share its strategic capacity and portfolio expansion plans. Samsung Biologics’ fifth plant is expected to be operational by April 2025, giving the company a total biomanufacturing capacity of 784,000 liters. The company is also constructing a standalone antibody-drug conjugate (ADC) facility, with the aim of completion by the end of this year.
Samsung Biologics will also showcase its strengths and capabilities in the contract development space. The company recently rebranded its CDO services to highlight the key service elements that the company has to offer with its new slogan – ‘Agile. Flexible. Focused on You.’
Samsung Biologics will also be meeting with existing and potential clients throughout the event to discuss how the company can support them to achieve development and manufacturing milestones.
Samsung Biologics will be attending the 2024 BIO International Convention in San Diego between June 3-6 this year.
The company plans to share its strategic capacity and portfolio expansion plans. Samsung Biologics’ fifth plant is expected to be operational by April 2025, giving the company a total biomanufacturing capacity of 784,000 liters. The company is also constructing a standalone antibody-drug conjugate (ADC) facility, with the aim of completion by the end of this year.
Samsung Biologics will also showcase its strengths and capabilities in the contract development space. The company recently rebranded its CDO services to highlight the key service elements that the company has to offer with its new slogan – ‘Agile. Flexible. Focused on You.’
Samsung Biologics will also be meeting with existing and potential clients throughout the event to discuss how the company can support them to achieve development and manufacturing milestones.